Community news|02/11/16

The Council reaches an agreement on ELVs for 11 new carcinogenic agents

Home > The news of EUROGIP and occupational risks in Europe > The Council reaches an agreement on ELVs for 11 new carcinogenic agents

On 13 October 2016, the EU Council reached an agreement to set exposure limit values (ELVs) for eleven new carcinogenic or mutagenic agents. The way is now open for discussions with the European Parliament.

Mr Jan Richter, Slovak Minister of Labour, the Family and Social Affairs and President of the Council, said: “With this agreement we take a major step forward in the combat against the primary cause of work-related deaths in the European Union. Our objective is to help save 100,000 lives over the next 50 years.”

The eleven new agents are as follows: respirable crystalline silica dust; 1,2-epoxypropane; 1,3-butadiene; 2-nitropropane; acrylamide; certain chromium (VI) compounds; ethylene oxide; o-toluidine; refractory ceramic fibres; bromoethylene; hydrazine.

The directive also revises the limit values concerning vinyl chloride monomer and hard wood dusts in the light of new scientific data.
New minimum requirements will be set concerning the elimination and reduction of all carcinogenic and mutagenic agents. Employers will also be obliged to identify and assess the risks related to workers’ exposure to carcinogenic (or mutagenic) agents, and they will be required to prevent this exposure if these risks are established.

When the technology makes it possible, it will be compulsory to provide for a harmless or less dangerous substitute process or chemical agent.
The legislation is due to be enacted in February 2017.

Discover other news



New EUROGIP study on the recognition of work-related mental disorders in Europe

It is now accepted that working conditions can have an impact on workers' mental health. The prevention of psychosocial risks has therefore become a priority in many countries. But the question of recognising psychological diseases as work-related is far from being unanimously accepted in Europe. EUROGIP devoted its latest study to this issue.